# Aegon LTD.: overview AEG · NYSE · CIK 769218 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aeg.md) · [Financials](/companies/aeg/financials.md) · [Filings](/companies/aeg/filings.md) · [Insiders](/companies/aeg/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [21.1](/filings/0001193125-23-076544.md) | [21.3](/filings/0001193125-23-076544.md) | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [117.2%](/filings/0001193125-23-076544.md) | [(164.7%)](/filings/0001193125-23-076544.md) | not reported | not reported | not reported | | Net margin | % | [9.4%](/filings/0001193125-23-076544.md) | [(2.7%)](/filings/0001193125-25-064638.md) | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.94](/filings/0001193125-23-076544.md) | [(0.30)](/filings/0001193125-25-064638.md) | [(0.12)](/filings/0001193125-25-064638.md) | [0.37](/filings/0001193125-25-064638.md) | not reported | | Free cash flow | $bn | [(1.9)](/filings/0001193125-24-086614.md) | [2.6](/filings/0001193125-25-064638.md) | [0.8](/filings/0001193125-26-124987.md) | [0.7](/filings/0001193125-26-124987.md) | [0.4](/filings/0001193125-26-124987.md) | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aeg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $376.7m | 44,635,184 | | Reduced −5,921,325 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $110.0m | 13,035,922 | | Added +1,294,211 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $50.0m | 5,920,668 | | Reduced −4,600,122 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $44.9m | 5,319,698 | | Added +757,276 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $43.8m | 5,184,353 | | Reduced −108,905 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $40.7m | 4,816,831 | | Reduced −815,013 | | [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $23.7m | 2,803,232 | | Added +2,574,489 | | [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $21.8m | 2,601,423 | | Added +1,551,234 | | [Quantinno Capital Management LP](/funds/1759654.md) | 2026-06-30 | $21.6m | 2,562,619 | | Added +827,268 | | [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $20.8m | 2,467,916 | | Added +16,401 | ## Recent filings [All 814 filings](/companies/aeg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-16 | 17:17 ET | [SCHEDULE 13D/A](/filings/0000950142-26-002779.md) | Ownership report, active investor, amended | 0000950142-26-002779 | | 2026-10-15 | 17:44 ET | [6-K](/filings/0001193125-26-422683.md) | Report of a foreign private issuer, period 2026-10-15 | 0001193125-26-422683 | | 2026-10-15 | 11:52 ET | [6-K](/filings/0001171843-26-006645.md) | Report of a foreign private issuer, period 2026-10-15 | 0001171843-26-006645 | | 2026-10-15 | 10:58 ET | [6-K](/filings/0001193125-26-422254.md) | Report of a foreign private issuer, period 2026-10-15 | 0001193125-26-422254 | | 2026-10-13 | 10:10 ET | [6-K](/filings/0001193125-26-419615.md) | Report of a foreign private issuer, period 2026-10-13 | 0001193125-26-419615 | | 2026-10-13 | 10:05 ET | [6-K](/filings/0001193125-26-419610.md) | Report of a foreign private issuer, period 2026-10-13 | 0001193125-26-419610 | | 2026-10-08 | 16:40 ET | [6-K](/filings/0001171843-26-006536.md) | Report of a foreign private issuer, period 2026-10-08 | 0001171843-26-006536 | | 2026-09-01 | 10:05 ET | [6-K](/filings/0001171843-26-005821.md) | Report of a foreign private issuer, period 2026-09-01 | 0001171843-26-005821 | | 2026-08-26 | 14:22 ET | [6-K](/filings/0001171843-26-005748.md) | Report of a foreign private issuer, period 2026-08-26 | 0001171843-26-005748 | | 2026-08-26 | 12:17 ET | [6-K](/filings/0001193125-26-365962.md) | Report of a foreign private issuer, period 2026-08-26 | 0001193125-26-365962 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-124987.md), filed Mar 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 769218 - Tickers: AEG, AEGOF, AEFC - Exchange: NYSE - SIC code: 6311 Life Insurance - State of incorporation: D0 - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.